Incidence of cardiovascular events after kidney transplantation and cardiovascular risk scores: study protocol

BackgroundCardiovascular disease (CVD) is the major cause of death after renal transplantation. Not only conventional CVD risk factors, but also transplant-specific risk factors can influence the development of CVD in kidney transplant recipients.The main objective of this study will be to determine the incidence of post-transplant CVD after renal transplantation and related factors. A secondary objective will be to examine the ability of standard cardiovascular risk scores (Framingham, Regicor, SCORE, and DORICA) to predict post-transplantation cardiovascular events in renal transplant recipients, and to develop a new score for predicting the risk of CVD after kidney transplantation.Methods/DesignObservational prospective cohort study of all kidney transplant recipients in the A Coruña Hospital (Spain) in the period 1981-2008 (2059 transplants corresponding to 1794 patients).The variables included will be: donor and recipient characteristics, chronic kidney disease-related risk factors, pre-transplant and post-transplant cardiovascular risk factors, routine biochemistry, and immunosuppressive, antihypertensive and lipid-lowering treatment. The events studied in the follow-up will be: patient and graft survival, acute rejection episodes and cardiovascular events (myocardial infarction, invasive coronary artery therapy, cerebral vascular events, new-onset angina, congestive heart failure, rhythm disturbances and peripheral vascular disease).Four cardiovascular risk scores were calculated at the time of transplantation: the Framingham score, the European Systematic Coronary Risk Evaluation (SCORE) equation, and the REGICOR (Registre Gironí del COR (Gerona Heart Registry)), and DORICA (Dyslipidemia, Obesity, and Cardiovascular Risk) functions.The cumulative incidence of cardiovascular events will be analyzed by competing risk survival methods. The clinical relevance of different variables will be calculated using the ARR (Absolute Risk Reduction), RRR (Relative Risk Reduction) and NNT (Number Needed to Treat).The ability of different cardiovascular risk scores to predict cardiovascular events will be analyzed by using the c index and the area under ROC curves. Based on the competing risks analysis, a nomogram to predict the probability of cardiovascular events after kidney transplantation will be developed.DiscussionThis study will make it possible to determine the post-transplant incidence of cardiovascular events in a large cohort of renal transplant recipients in Spain, to confirm the relationship between traditional and transplant-specific cardiovascular risk factors and CVD, and to develop a score to predict the risk of CVD in these patients.

[1]  R. Foley,et al.  Epidemiology of cardiovascular disease in chronic renal disease , 2000 .

[2]  A. Wierzbicki,et al.  Cardiovascular disease in renal allograft recipients is associated with elevated sialic acid or markers of inflammation , 2004, Clinical transplantation.

[3]  Z. Massy,et al.  Hyperhomocysteinaemia: a significant risk factor for cardiovascular disease in renal transplant recipients. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[5]  J. Marrugat,et al.  Estimacin del riesgo coronario en Espaa mediante la ecuacin de Framingham calibrada , 2003 .

[6]  Shah Ebrahim,et al.  European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. , 2003 .

[7]  T. Lumley,et al.  Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker , 2000, Biometrics.

[8]  Shah Ebrahim,et al.  European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. , 2004, European heart journal.

[9]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[10]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[11]  D. Norman,et al.  Late Steroid Withdrawal and Cardiovascular Events in Kidney Transplant Recipients , 2008, Transplantation.

[12]  P. Ho,et al.  Predictors of cardiovascular events and associated mortality within two years of kidney transplantation. , 2004, Transplantation proceedings.

[13]  Ronald M. Lauer,et al.  National Cholesterol Education Program. Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction: executive summary. National Heart, Lung and Blood Institute, National Institutes of Health. , 1991, Archives of internal medicine.

[14]  J. Mckenney,et al.  Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) , 1993, JAMA.

[15]  L. Wilkins,et al.  National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). , 1994, Circulation.

[16]  L. Miller.  Cardiovascular Toxicities of Immunosuppressive Agents , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[17]  Detection.  The sixth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) , 1997 .

[18]  B. Kasiske,et al.  Explained and unexplained ischemic heart disease risk after renal transplantation. , 2000, Journal of the American Society of Nephrology : JASN.

[19]  D. Atar,et al.  JOINT ESC GUIDELINES 2016 European Guidelines on cardiovascular disease prevention in clinical practice – Web Addenda , 2016 .

[20]  S. Chadban,et al.  Reduction in Cardiovascular Death After Kidney Transplantation , 2010, Transplantation.

[21]  M. Arias,et al.  Proteinuria is an independent risk factor of cardiovascular disease in renal transplant patient. , 2002, Transplantation proceedings.

[22]  S. Pita-Fernández,et al.  Incidence of cardiovascular events in renal transplant recipients and clinical relevance of modifiable variables. , 2007, Transplantation proceedings.

[23]  A. Kazory,et al.  Predicting coronary heart disease in renal transplant recipients: a prospective study. , 2004, Kidney international.

[24]  H. Tunstall-Pedoe,et al.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. , 2003, European heart journal.

[25]  The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V) , 1993, Archives of internal medicine.

[26]  R. Zietse,et al.  PROTEINURIA AFTER RENAL TRANSPLANTATION AFFECTS NOT ONLY GRAFT SURVIVAL BUT ALSO PATIENT SURVIVAL , 2001, Transplantation.

[27]  A. Levey,et al.  Hyperhomocysteinemia in Renal Transplant Recipients , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[28]  R. D'Agostino,et al.  [Coronary risk estimation in Spain using a calibrated Framingham function]. , 2003, Revista espanola de cardiologia.

[29]  Shah Ebrahim,et al.  Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) , 2007 .

[30]  G. Borm,et al.  Associations between pre‐kidney‐transplant risk factors and post‐transplant cardiovascular events and death , 2008, Transplant international : official journal of the European Society for Organ Transplantation.

[31]  S. Sans,et al.  [Calibrating the SCORE cardiovascular risk chart for use in Spain]. , 2007, Revista espanola de cardiologia.

[32]  M. Arias,et al.  Posttransplant diabetes is a cardiovascular risk factor in renal transplant patients. , 2003, Transplantation proceedings.

[33]  Á. Alonso,et al.  Causes of death and mortality risk factors. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[34]  B. Kasiske,et al.  Acute myocardial infarction and kidney transplantation. , 2006, Journal of the American Society of Nephrology : JASN.

[35]  A. Jardine,et al.  Renal Dysfunction as a Risk Factor for Mortality and Cardiovascular Disease in Renal Transplantation: Experience from the Assessment of Lescol in Renal Transplantation Trial , 2005, Transplantation.

[36]  S. Monereo,et al.  [Tables of coronary risk evaluation adapted to the Spanish population: the DORICA study]. , 2004, Medicina clinica.

[37]  H. Meier‐Kriesche,et al.  Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation1,2 , 2003, Transplantation.

[38]  L. Wilkins.  National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). , 1994 .

[39]  M. Raftery,et al.  Pretransplantation levels of C-reactive protein predict all-cause and cardiovascular mortality, but not graft outcome, in kidney transplant recipients. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[40]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[41]  F. Cosio,et al.  Patient survival after renal transplantation: I. The impact of dialysis pre-transplant. , 1998, Kidney international.

[42]  K. Anderson,et al.  An updated coronary risk profile. A statement for health professionals. , 1991, Circulation.

[43]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .

[44]  Daniel B. Mark,et al.  TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS , 1996 .

[45]  Curt D. Furberg,et al.  Lipoprotein Management in Patients With Cardiometabolic Risk , 2008, Diabetes Care.

[46]  Shah Ebrahim,et al.  Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts) , 2007 .

[47]  S. Aakhus,et al.  Cardiovascular morbidity and risk factors in renal transplant patients. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[48]  M. H. Gault,et al.  Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.

[49]  I. Graham,et al.  Calibración de la tabla SCORE de riesgo cardiovascular para España , 2007 .

[50]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[51]  B. Ponte,et al.  Evolution of rejection rates and kidney graft survival: a historical analysis. , 2009, Transplantation proceedings.

[52]  M. Schnitzler.  Diabetes Mellitus After Kidney Transplantation in the United States , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[53]  B. Maes,et al.  Risk Factors for Cardiovascular Events After Successful Renal Transplantation , 2005, Transplantation.

[54]  M. Mori,et al.  Cardiovascular events following renal transplantation: role of traditional and transplant-specific risk factors. , 2006, Kidney international.

[55]  Lluís Serra Majem,et al.  Tablas de evaluación del riesgo coronario adaptadas a la población española. Estudio DORICA , 2004 .

[56]  F. Harrell,et al.  Evaluating the yield of medical tests. , 1982, JAMA.

[57]  A. Ojo.  Cardiovascular Complications After Renal Transplantation and Their Prevention , 2006, Transplantation.

[58]  B. Kiberd,et al.  Cardiovascular outcomes in the outpatient kidney transplant clinic: the Framingham risk score revisited. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[59]  Shah Ebrahim,et al.  European guidelines on cardiovascular disease prevention in clinical practice , 2004 .

[60]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[61]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[62]  Guía Europea de Prevención Cardiovascular en la Práctica Clínica. Adaptación española del CEIPC 2008 , 2009 .

[63]  E. Grossi.  BMC Cardiovascular Disorders , 2007 .

[64]  M. Arias,et al.  Proteinuria: a new marker of long-term graft and patient survival in kidney transplantation. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[65]  R. Gray.  A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .